BioHealth News
Unveiling the Key to Healthcare Innovation Success: The NIH’s TABA Needs Assessment Report
Are you navigating the complex terrain of healthcare innovation? The National Institutes of Health (NIH) offers a powerful tool to guide your journey: the…
Read More
ChromaTan, Inc. Selected as a BLUE KNIGHT™ Company with laboratory space at JLABS @ Washington, DC
LOWER GWYNEDD, Penn.--(BUSINESS WIRE)--ChromaTan, Inc., a bioprocess development company revolutionizing the 123-year-old traditional batch biopurification process through transformational next-generation biomanufacturing solutions, announced today that…
Read More
Breaking Barriers in Enteral Nutrition: Luminoah’s Innovative MedTech with Neal Piper on BioTalk
Are you ready to explore the transformative world of MedTech and its profound impact on healthcare? Join us in this episode of BioTalk with…
Read More
President Biden Intends to Appoint Dr. W. Kimryn Rathmell as Director of the National Cancer Institute
Today, President Joe Biden announced his intent to appoint Dr. W. Kimryn Rathmell as the 17th Director of the National Cancer Institute (NCI), the federal…
Read More
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicines ROCKVILLE, Md., Nov. 16, 2023 (GLOBE…
Read More
Arcellx and Kite Announce Expansion in Strategic Partnership
-- Arcellx to receive $200M equity investment at $61.68 per share and an $85 million upfront cash payment -- -- Kite exercises option to…
Read More
BizJournals – Children’s National Hospital spinout ReveraGen BioPharma gearing up for muscular dystrophy drug launch
By Sara Gilgore - Staff Reporter November 14, 2023, 03:14pm EST Updated 18 hours ago Rockville’s ReveraGen BioPharma Inc., a 15-year-old Children’s National Hospital spinout, is…
Read More
Children’s National Hospital selected as member of ARPA-H Investor Catalyst Hub spoke network
The hospital will advocate for the unique needs of children as part of nationwide network working to accelerate transformative health solutions November 13, 2023…
Read More
Selecta Biosciences Announces Merger with Cartesian Therapeutics
WATERTOWN, Mass. and GAITHERSBURG, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB) (the Company) today announced that it has merged with…
Read More
BioTalk – Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)
What are the latest advancements in cancer research and innovation? Join us in this episode of BioTalk with Rich Bendis as we explore the…
Read More
BioHealth Innovation, Inc. Welcomes Dr. Eric S. Edwards of Phlow Corporation to the Board of Directors and Appoints Donna J. Edmonds of BRAINBox Solutions, Inc. as Vice Chair
ROCKVILLE, MARYLAND, November 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading organization dedicated to supporting and advancing the BioHealth industry, is pleased to…
Read More
The NHLBI is accepting applications for the I-Corps at NIH™ Program
The NHLBI is accepting applications for the I-Corps at NIH™ Program, which provides funding, mentoring, and networking opportunities to current Phase I SBIR/STTR awardees and Fast-Track awardees in the first phase of…
Read More
VLP Therapeutics group announces 3rd closing of funding to develop cancer, infectious disease vaccines; establish investigational vaccine manufacturing facility
US-based biotech company VLP Therapeutics, Inc. (VLPT) and its Tokyo-based group company VLP Therapeutics Japan, Inc. (VLPT Japan) together announced on November 8 the…
Read More
Emergent BioSolutions Submits Supplemental Biologics License Application Seeking U.S. FDA Approval of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) for Immunization Against Mpox
GAITHERSBURG, Md., November 7, 2023 – Emergent (NYSE: EBS) has recently submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug…
Read More
Irazú Oncology and University of Maryland, Baltimore Mark Anniversary of Exclusive License for Development of Colorectal Cancer Vaccine
BALTIMORE, MD, November 7, 2023 –Irazú Oncology, LLC, a biotechnology research company working to develop the next generation of cancer vaccines, and University of…
Read More